Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Cardiology/Vascular Diseases
Atrial Fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Atrial Fibrillation study for the evaluation and safety of a medication for people with atrial fibrillation.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation (EngageAFTIMI48)
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Global Study to Assess the Safety and Effectiveness of DU-176b vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation (EngageAFTIMI48)
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of DU-176b Versus Warfarin In Subjects With Atrial Fibrillation - Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation (ENGAGE AF – TIMI 48)
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Do you have ATRIAL FIBRILLATION and planned ANTICOAGULANT THERAPY?
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Has your doctor told you that you have Atrial Fibrillation (AF)?
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Atrial Fibrilation- Multidose Safety and Tolerability Study of (Arikace™) for Inhalation In Cystic Fibrosis Patients
Atrial Fibrillation- Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)
Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-Dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation (BOREALIS-AF)
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
ATRIAL FIBRILLATION: Have you been diagnosed with Atrial Fibrillation in the last year?
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Atrial Fibrillation - Houston, TX
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Atrial Fibillation patients undergoing cardioversion wanted for research study
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
Are you a candidate for this AFib study? You might be if you have experienced AFib symptoms in the last three months. This study will evaluate the effectiveness and safety of Lovaza? (Omega-3-Acid Ethyl Esters) in recurrent, symptomatic atrial fibrillation
Have you been diagnosed with atrial fibrillation (A-Fib)? You may be a candidate for an A-Fib study. This study will evaluate the effectiveness and safety of idrabiotaparinux for the prevention of stroke in patients with A-Fib.
